Tirzepatide versus dulaglutide in heart failure: another SURPASS attempt yielding a tie.

Busti M, Canonico ME, Keramida K, Palazzuoli A, Kato E, Sakata Y, Alexy T, Grupper A, Nodari S, Ojji DB, Sverdlov AL, Guimaraes PO, Musella F, Ambrosy AP, Girerd N, Monzo L

Open source

DOI: 10.1007/s10741-026-10627-1
Published: 2026 Apr 15
Container: Heart failure reviews
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10741-026-10627-1,
  title = {Tirzepatide versus dulaglutide in heart failure: another SURPASS attempt yielding a tie.},
  author = {Busti M and Canonico ME and Keramida K and Palazzuoli A and Kato E and Sakata Y and Alexy T and Grupper A and Nodari S and Ojji DB and Sverdlov AL and Guimaraes PO and Musella F and Ambrosy AP and Girerd N and Monzo L},
  year = {2026},
  journal = {Heart failure reviews},
  doi = {10.1007/s10741-026-10627-1},
  url = {https://doi.org/10.1007/s10741-026-10627-1}
}

RIS

TY  - JOUR
TI  - Tirzepatide versus dulaglutide in heart failure: another SURPASS attempt yielding a tie.
AU  - Busti M
AU  - Canonico ME
AU  - Keramida K
AU  - Palazzuoli A
AU  - Kato E
AU  - Sakata Y
AU  - Alexy T
AU  - Grupper A
AU  - Nodari S
AU  - Ojji DB
AU  - Sverdlov AL
AU  - Guimaraes PO
AU  - Musella F
AU  - Ambrosy AP
AU  - Girerd N
AU  - Monzo L
PY  - 2026
JO  - Heart failure reviews
DO  - 10.1007/s10741-026-10627-1
UR  - https://doi.org/10.1007/s10741-026-10627-1
ER  -

APA

M, B., ME, C., K, K., A, P., E, K., Y, S., T, A., A, G., S, N., DB, O., AL, S., PO, G., F, M., AP, A., N, G., & L, M. (2026). Tirzepatide versus dulaglutide in heart failure: another SURPASS attempt yielding a tie.. Heart failure reviews. https://doi.org/10.1007/s10741-026-10627-1

Source records

pubmed · retrieved 2026-09-26T11:10:51.649Z